1Goldstraw P, Chansky K, Crewley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer [J]. J Thorac Oncol, 2016, 11(1): 39-51.
2Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer [J]. J Thorac Oncol, 2015, 10(7): 990- 1003.
3Asamura H, Chansky K, Crowley J, et al. The international association for the study of lung cancer staging project: proposals for revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer[J]. J Thorac Oncol, 2015, 10(12): 1675-1684.
4Eberhardt WE, Mitchell A, Crowley J, et al. The IASLC lung cancer staging project: proposats for revision of the M descriptors in the forthcoming eighth edition of the TNM classification for lung cancer[J]. J Thorac Oncol, 2015, 10(11): 1515- 1522.
5Rami-Porta R, Bolejack V, Giroux DJ, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer[J]. J Thorac Oncol, 2014, 9(11): 1618-1624.
6Goldstraw P, Crewley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours [J]. J Thorac Oncol, 2007, 2(8):706-714.
7Hsu HS, Huang PI, Chang YL, et al. Cucurbitacin I inhibits tumorigenic ability and enhances radioehemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells [J]. Cancer, 2011, 117 (13): 2970-2985.
8Normolle DP, Donnenherg VS, Donnenberg AD, et al. Statistical classification of multivariate flow cytometry data analyzed by manual gating:Stem,progenitor, and epithelial marker expression in nonsmall cell lung cancer and normal lung [J]. Cytometry A, 2013, 83 (1): 150-160.
9Gottschling S, Jensen K, Warth A, et al. Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis[J]. Eur Respir J, 2013, 41(3): 656-663.
10Sterlacci W, Savic S, Fiegl M, et al. Putative stem cell markers in non-small-cell lung cancer:A clinicopathologic characterization [J].J Thorac Oncol, 2014, 9(1): 41-49.
